334 related articles for article (PubMed ID: 31754404)
1. CACYBP Enhances Cytoplasmic Retention of P27
Lian YF; Huang YL; Zhang YJ; Chen DM; Wang JL; Wei H; Bi YH; Jiang ZW; Li P; Chen MS; Huang YH
Theranostics; 2019; 9(26):8392-8408. PubMed ID: 31754404
[TBL] [Abstract][Full Text] [Related]
2. CacyBP/SIP nuclear translocation regulates p27Kip1 stability in gastric cancer cells.
Niu YL; Li YJ; Wang JB; Lu YY; Liu ZX; Feng SS; Hu JG; Zhai HH
World J Gastroenterol; 2016 Apr; 22(15):3992-4001. PubMed ID: 27099442
[TBL] [Abstract][Full Text] [Related]
3. CacyBP/SIP inhibits the migration and invasion behaviors of glioblastoma cells through activating Siah1 mediated ubiquitination and degradation of cytoplasmic p27.
Yan S; Li A; Liu Y
Cell Biol Int; 2018 Feb; 42(2):216-226. PubMed ID: 29024247
[TBL] [Abstract][Full Text] [Related]
4. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
5. MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability.
Wan C; Hou S; Ni R; Lv L; Ding Z; Huang X; Hang Q; He S; Wang Y; Cheng C; Gu XX; Xu G; Shen A
Oncogene; 2015 Jan; 34(2):237-45. PubMed ID: 24336329
[TBL] [Abstract][Full Text] [Related]
6. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27
Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated p27Kip1 on Thr157 is an important prognosis in human hepatocellular carcinoma in vivo and in vitro.
He S; Lu M; Xue W; Wang Y; Zhao Y; Gao S; Ke Q; Liu Y; Li P; Cui X; Cheng C; Shen A
Med Oncol; 2011 Mar; 28(1):94-104. PubMed ID: 20108172
[TBL] [Abstract][Full Text] [Related]
8. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
[TBL] [Abstract][Full Text] [Related]
9. Mutations of phosphorylation sites Ser10 and Thr187 of p27Kip1 abolish cytoplasmic redistribution but do not abrogate G0/1 phase arrest in the HepG2 cell line.
Guan X; Chen L; Wang J; Geng H; Chu X; Zhang Q; Du L; De W
Biochem Biophys Res Commun; 2006 Sep; 347(3):601-7. PubMed ID: 16842750
[TBL] [Abstract][Full Text] [Related]
10. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
[TBL] [Abstract][Full Text] [Related]
11. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL
Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239
[TBL] [Abstract][Full Text] [Related]
12. Expression of Pirh2, a p27(Kip1) ubiquitin ligase, in hepatocellular carcinoma: correlation with p27(Kip1) and cell proliferation.
Huang X; Qian X; Cheng C; He S; Sun L; Ke Q; Zhang L; Pan X; He F; Wang Q; Meng J; Ni R; Shen A
Hum Pathol; 2011 Apr; 42(4):507-15. PubMed ID: 21236467
[TBL] [Abstract][Full Text] [Related]
13. CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells.
Chen X; Mo P; Li X; Zheng P; Zhao L; Xue Z; Ren G; Han G; Wang X; Fan D
Mol Carcinog; 2011 Oct; 50(10):804-10. PubMed ID: 21268134
[TBL] [Abstract][Full Text] [Related]
14. Modification of p27 with O-linked N-acetylglucosamine regulates cell proliferation in hepatocellular carcinoma.
Qiu H; Liu F; Tao T; Zhang D; Liu X; Zhu G; Xu Z; Ni R; Shen A
Mol Carcinog; 2017 Jan; 56(1):258-271. PubMed ID: 27175940
[TBL] [Abstract][Full Text] [Related]
15. Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinoma.
Xu H; Choe C; Shin SH; Park SW; Kim HS; Jung SH; Yim SH; Kim TM; Chung YJ
Exp Mol Med; 2014 May; 46(5):e97. PubMed ID: 24854087
[TBL] [Abstract][Full Text] [Related]
16. Nucleostemin/GNL3 promotes nucleolar polyubiquitylation of p27
Hu B; Hua L; Ni W; Wu M; Yan D; Chen Y; Lu C; Chen B; Wan C
Cancer Lett; 2017 Mar; 388():220-229. PubMed ID: 27998760
[TBL] [Abstract][Full Text] [Related]
17. Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma.
Wang J; Zhang X; Ma X; Chen D; Cai M; Xiao L; Li J; Huang Z; Huang Y; Lian Y
J Exp Clin Cancer Res; 2023 Nov; 42(1):303. PubMed ID: 37968706
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of miR-221 and its inverse correlation with p27Kip¹ in hepatocellular carcinoma.
Fu X; Wang Q; Chen J; Huang X; Chen X; Cao L; Tan H; Li W; Zhang L; Bi J; Su Q; Chen L
Mol Biol Rep; 2011 Jun; 38(5):3029-35. PubMed ID: 20146005
[TBL] [Abstract][Full Text] [Related]
19. Silibinin efficacy against human hepatocellular carcinoma.
Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
